AAAAAA

   
Results: 1-25 |
Results: 25
Heparin antibodies and thromboembolism in heparin-coated and noncoated ventricular assist devices
Authors: Koster, A Loebe, M Sodian, R Potapov, EV Hansen, R Muller, J Mertzlufft, F Crystal, GJ Kuppe, H Hetzer, R
Citation: A. Koster et al., Heparin antibodies and thromboembolism in heparin-coated and noncoated ventricular assist devices, J THOR SURG, 121(2), 2001, pp. 331-335
Heparin-induced thrombocytopenia (HIT) - Problem and their importance for ENT medicine
Authors: Kleinschmidt, S Mertzlufft, F Bach, F Plinkert, RK
Citation: S. Kleinschmidt et al., Heparin-induced thrombocytopenia (HIT) - Problem and their importance for ENT medicine, HNO, 49(10), 2001, pp. 854-864
Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban
Authors: Koster, A Kulucka, M Bach, F Meyer, O Fischer, T Mertzlufft, F Loebe, M Hetzer, R Kuppe, H
Citation: A. Koster et al., Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban, ANESTHESIOL, 94(2), 2001, pp. 245-251
Prevalence and persistence of heparin/platelet factor 4 antibodies in patients with heparin coated and noncoated ventricular assist devices
Authors: Koster, A Sanger, S Hansen, R Sodian, R Mertzlufft, F Harke, C Kuppe, H Hetzer, R Loebe, M
Citation: A. Koster et al., Prevalence and persistence of heparin/platelet factor 4 antibodies in patients with heparin coated and noncoated ventricular assist devices, ASAIO J, 46(3), 2000, pp. 319-322
Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: A 1-year experience in 57 patients
Authors: Koster, A Hansen, R Kuppe, H Hetzer, R Crystal, GJ Mertzlufft, F
Citation: A. Koster et al., Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: A 1-year experience in 57 patients, J CARDIOTHO, 14(3), 2000, pp. 243-248
Hirudin monitoring using the TAS ecarin clotting time in patients with heparin-induced thrombocytopenia type II
Authors: Koster, A Hansen, R Grauhan, O Hausmann, H Bauer, M Hetzer, R Kuppe, H Mertzlufft, F
Citation: A. Koster et al., Hirudin monitoring using the TAS ecarin clotting time in patients with heparin-induced thrombocytopenia type II, J CARDIOTHO, 14(3), 2000, pp. 249-252
Acute heparin-induced thrombocytopenia type II during cardiopulmonary bypass
Authors: Koster, A Crystal, GJ Kuppe, H Mertzlufft, F
Citation: A. Koster et al., Acute heparin-induced thrombocytopenia type II during cardiopulmonary bypass, J CARDIOTHO, 14(3), 2000, pp. 300-303
Management of urgent high-risk cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and coexisting disorders of renal function: Use of heparin and epoprostenol combined with on-line monitoring of platelet function
Authors: Mertzlufft, F Kuppe, H Koster, A
Citation: F. Mertzlufft et al., Management of urgent high-risk cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and coexisting disorders of renal function: Use of heparin and epoprostenol combined with on-line monitoring of platelet function, J CARDIOTHO, 14(3), 2000, pp. 304-308
In vitro cross-reactivity of danaparoid sodium in patients with heparin-induced thrombocytopenia type II undergoing cardiovascular surgery
Authors: Koster, A Meyer, O Hausmann, H Kuppe, H Hetzer, R Mertzlufft, F
Citation: A. Koster et al., In vitro cross-reactivity of danaparoid sodium in patients with heparin-induced thrombocytopenia type II undergoing cardiovascular surgery, J CLIN ANES, 12(4), 2000, pp. 324-327
A quick assay for monitoring recombinant hirudin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: Adaptation of the ecarin clotting time to the ACT II device
Authors: Koster, A Loebe, M Hansen, R Bauer, M Mertzlufft, F Kuppe, H Hetzer, R
Citation: A. Koster et al., A quick assay for monitoring recombinant hirudin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: Adaptation of the ecarin clotting time to the ACT II device, J THOR SURG, 119(6), 2000, pp. 1278-1283
Pharyngolaryngoscopic results in patients with OSAS and rhonchopathy
Authors: Steinhart, H Kuhn-Lohmann, JC Gewalt, K Constantinidis, J Mertzlufft, F Petak, M Iro, H
Citation: H. Steinhart et al., Pharyngolaryngoscopic results in patients with OSAS and rhonchopathy, HNO, 48(12), 2000, pp. 917-921
Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitor tirofiban as anticoagulant
Authors: Koster, A Loebe, M Mertzlufft, F Kuppe, H Hetzer, R
Citation: A. Koster et al., Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitor tirofiban as anticoagulant, ANN THORAC, 70(6), 2000, pp. 2160-2161
Reliability of the heparin management test for monitoring high levels of unfractionated heparin - In vitro findings in volunteers versus in vivo findings during cardiopulmonary bypass
Authors: Mertzlufft, F Koster, A Hansen, R Risch, A Kuppe, H Kubel, B Crystal, GJ
Citation: F. Mertzlufft et al., Reliability of the heparin management test for monitoring high levels of unfractionated heparin - In vitro findings in volunteers versus in vivo findings during cardiopulmonary bypass, ANESTHESIOL, 92(6), 2000, pp. 1594-1602
A quick anti-Xa-activity-based whole blood coagulation assay for monitoring unfractionated heparin during cardiopulmonary bypass: A pilot investigation
Authors: Hansen, R Koster, A Kukucka, M Mertzlufft, F Kuppe, H
Citation: R. Hansen et al., A quick anti-Xa-activity-based whole blood coagulation assay for monitoring unfractionated heparin during cardiopulmonary bypass: A pilot investigation, ANESTH ANAL, 91(3), 2000, pp. 533-538
Elimination of recombinant hirudin by modified ultrafiltration during simulated cardiopulmonary bypass: Assessment of different filter systems
Authors: Koster, A Merkle, F Hansen, R Loebe, M Kuppe, H Hetzer, R Crystal, GJ Mertzlufft, F
Citation: A. Koster et al., Elimination of recombinant hirudin by modified ultrafiltration during simulated cardiopulmonary bypass: Assessment of different filter systems, ANESTH ANAL, 91(2), 2000, pp. 265-269
Fechtner's syndrome: Considerations of anesthetic management
Authors: Mertzlufft, F Koster, A Steinhart, H Schenk, JF Crystal, GJ
Citation: F. Mertzlufft et al., Fechtner's syndrome: Considerations of anesthetic management, ANESTH ANAL, 90(6), 2000, pp. 1372-1375
Cardiovascular surgery without cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II using anticoagulation with recombinant hirudin
Authors: Koster, A Kuppe, H Crystal, GJ Mertzlufft, F
Citation: A. Koster et al., Cardiovascular surgery without cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II using anticoagulation with recombinant hirudin, ANESTH ANAL, 90(2), 2000, pp. 292-298
Preanalytical errors on the termination of arterial O-2-partial pressure and their impact on the AaDO(2)
Authors: Risch, A Biedler, A Mertzlufft, F
Citation: A. Risch et al., Preanalytical errors on the termination of arterial O-2-partial pressure and their impact on the AaDO(2), ANAESTHESIS, 49(1), 2000, pp. 29-33
Upper airway collapsibility in habitual snorers and sleep apneics: Evaluation with drug-induced sleep endoscopy
Authors: Steinhart, H Kuhn-Lohmann, J Gewalt, K Constantnidis, J Mertzlufft, F Iro, H
Citation: H. Steinhart et al., Upper airway collapsibility in habitual snorers and sleep apneics: Evaluation with drug-induced sleep endoscopy, ACT OTO-LAR, 120(8), 2000, pp. 990-994
Remifentanil and propofol without muscle relaxants or with different dosesof rocuronium for tracheal intubation in outpatient anaesthesia
Authors: Schlaich, N Mertzlufft, F Soltesz, S Fuchs-Buder, T
Citation: N. Schlaich et al., Remifentanil and propofol without muscle relaxants or with different dosesof rocuronium for tracheal intubation in outpatient anaesthesia, ACT ANAE SC, 44(6), 2000, pp. 720-726
Antioxidative resuscitation solution prevents leukocyte adhesion in the liver after hemorrhagic shock
Authors: Bauer, C Walcher, F Holanda, M Mertzlufft, F Larsen, R Marzi, I
Citation: C. Bauer et al., Antioxidative resuscitation solution prevents leukocyte adhesion in the liver after hemorrhagic shock, J TRAUMA, 46(5), 1999, pp. 886-893
Continuous sedation during spinal anaesthesia: gamma-hydroxybutyrate vs. propofol
Authors: Kleinschmidt, S Schellhase, C Mertzlufft, F
Citation: S. Kleinschmidt et al., Continuous sedation during spinal anaesthesia: gamma-hydroxybutyrate vs. propofol, EUR J ANAES, 16(1), 1999, pp. 23-30
Acute unilateral deafness and contralateral hearing loss following inguinal hernia repair under controlled anesthesia
Authors: Constantinidis, J Mertzlufft, F Steinhart, H
Citation: J. Constantinidis et al., Acute unilateral deafness and contralateral hearing loss following inguinal hernia repair under controlled anesthesia, HNO, 47(10), 1999, pp. 907-911
Pre-analytic errors in the determination of arterial O-2-partial pressure under hyperoxic conditions
Authors: Risch, A Biedler, A Mertzlufft, F
Citation: A. Risch et al., Pre-analytic errors in the determination of arterial O-2-partial pressure under hyperoxic conditions, ANAESTHESIS, 48(8), 1999, pp. 533-537
Evaluation of lactate measurement in blood and plasma with biosensor technology: a comparison of methods
Authors: Biedler, A Risch, A Mertzlufft, F
Citation: A. Biedler et al., Evaluation of lactate measurement in blood and plasma with biosensor technology: a comparison of methods, ANAESTHESIS, 47(12), 1998, pp. 968-974
Risultati: 1-25 |